The U.S. Food and Drug Administration has approved Merck's (NYSE: MRK) Keytruda (pembrolizumab) and Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA